drugset / Trial / NCT00604032

Study to Determine the Phototoxity of Atralin (Tretinoin) Gel, 0.05%

NCT00604032

Phase 1 Completed 60 enrolled Coria Laboratories, Ltd.
RandomizedSingle-groupSingle-blind

Summary

To assess the potential of tretnoin gel 0.05% to produce phototoxic reactions, measured as skin reactions 24 and 48 hours after UV radiation of drug on skin.

Timeline

Start
2008-01
Primary completion
2008-01
Completion
2008-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tretinoin Small molecule 0.05 %

Indications

No indication recorded.